Disclosure of Operating Profit Excluding Growth Investment Expenses, Goodwill and Intangible Asset Amortization
First written in FY2024-Q2. 6 of 7 entries say "Advanced", first in FY2024-Q3. Latest entry: FY2026.
5 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「Operating profit excluding items ① and ② increased from ¥59,008 million to ¥59,567 million, an increase of ¥558 million, or 0.9%, from the same period of the previous year.」
Operating profit excluding business investment expenses and other expenses and goodwill and intangible asset amortization expenses amounted to ¥59,567 million, an increase of 0.9% from the previous fiscal year. - FY2026-H1AdvancedAnnual report
「Operating profit excluding items ① and ② 28,596 29,618 +1,021 +3.6%」
Operating profit excluding business investment expenses and other expenses and goodwill and intangible asset amortization expenses increased 3.6% year on year to ¥29,618 million, and the Company continued to disclose profit growth on an expense-excluded basis. - FY2025AdvancedAnnual report
「Operating profit excluding items ① and ② increased from ¥55,159 million to ¥59,008 million, an increase of ¥3,849 million, or 7.0%, from the same period of the previous year.」
Operating profit excluding business investment expenses and other expenses and goodwill and intangible asset amortization expenses amounted to ¥59,008 million, an increase of 7.0% from the previous fiscal year. - FY2025-H1AdvancedAnnual report
「Operating profit excluding items ① and ② increased from ¥27,159 million to ¥28,596 million, an increase of ¥1,437 million, or 5.3%, from the same period of the previous year.」
Operating profit excluding business investment expenses and other expenses and goodwill and intangible asset amortization expenses continued to be disclosed, increasing 5.3% year on year to ¥28,596 million. - FY2024AdvancedAnnual report
「As a result, operating profit declined, but this was attributable to the recognition from the current period of business investment expenses required as a source of future business growth and the amortization expenses described above. Excluding these factors, operating profit increased by ¥2,011 million, or 3.8%, from the previous fiscal year.」
For FY2024, operating profit excluding business investment expenses of ¥5,772 million and goodwill and intangible asset amortization expenses of ¥2,056 million increased 3.8% from the previous fiscal year. - FY2024-Q3AdvancedAnnual report
「As a result, operating profit declined, but this was attributable to the recognition from the current period of business investment expenses required as a source of future business growth and the amortization expenses described above. Excluding these factors, operating profit increased by ¥2,575 million, or 6.2%, from the same period of the previous year.」
For the cumulative FY2024-Q3 period, business investment expenses of ¥5,500 million and goodwill and intangible asset amortization expenses of ¥1,542 million weighed on operating profit, while operating profit excluding these expenses amounted to ¥44,257 million, an increase of 6.2% year on year. - FY2024-Q2First statedAnnual report
「As a result, operating profit declined, but this was attributable to the recognition from the current period of business investment expenses required as a source of future business growth and the amortization expenses described above. Excluding these factors, operating profit increased by ¥1,565 million, or 6.1%, from the same period of the previous year.」
Operating profit excluding business investment expenses of ¥5,500 million and ¥1,028 million in goodwill and intangible asset amortization expenses associated with the growth investments set out in the 2027 Medipal Medium-Term Vision was disclosed, representing a 6.1% year-on-year increase.